Institution
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Nonprofit•Le Grand-Saconnex, Switzerland•
About: The Global Fund to Fight AIDS, Tuberculosis and Malaria is a nonprofit organization based out in Le Grand-Saconnex, Switzerland. It is known for research contribution in the topics: Population & Public health. The organization has 187 authors who have published 294 publications receiving 10636 citations. The organization is also known as: The Global Fund.
Topics: Population, Public health, Acquired immunodeficiency syndrome (AIDS), Global health, Malaria
Papers published on a yearly basis
Papers
More filters
••
Harvard University1, Pan American Health Organization2, Livestrong Foundation3, The Global Fund to Fight AIDS, Tuberculosis and Malaria4, American Society of Clinical Oncology5, China Medical Board6, University of California, San Francisco7, Seattle Cancer Care Alliance8, Global Forum for Health Research9, Imperial College London10, Public Health Foundation of India11, Columbia University12, King Hussein Cancer Center13, American Cancer Society14
TL;DR: The public health community's assumption that cancers will remain untreated in poor countries is challenged, and the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment is noted.
662 citations
••
TL;DR: A strategic investment framework is proposed that is intended to support better management of national and international HIV/AIDS responses than exists with the present system and would avert 12·2 million new HIV infections and 7·4 million deaths from AIDS between 2011 and 2020.
478 citations
••
Brigham and Women's Hospital1, Johns Hopkins University2, University of London3, Institute for Health Metrics and Evaluation4, The Global Fund to Fight AIDS, Tuberculosis and Malaria5, Bill & Melinda Gates Foundation6, University of Colorado Denver7, University of Bristol8, University College London9
TL;DR: In settings without neonatal intensive care, the impairment rate is low due to high mortality, which is relevant for the scale-up of basic neonatal resuscitation, but rates of impairment are highest in middle-income countries where neonatalintensive care was more recently introduced, but quality may be poor.
Abstract: Intrapartum hypoxic events (“birth asphyxia”) may result in stillbirth, neonatal or postneonatal mortality, and impairment. Systematic morbidity estimates for the burden of impairment outcomes are currently limited. Neonatal encephalopathy (NE) following an intrapartum hypoxic event is a strong predictor of long-term impairment. Linear regression modeling was conducted on data identified through systematic reviews to estimate NE incidence and time trends for 184 countries. Meta-analyses were undertaken to estimate the risk of NE by sex of the newborn, neonatal case fatality rate, and impairment risk. A compartmental model estimated postneonatal survivors of NE, depending on access to care, and then the proportion of survivors with impairment. Separate modeling for the Global Burden of Disease 2010 (GBD2010) study estimated disability adjusted life years (DALYs), years of life with disability (YLDs), and years of life lost (YLLs) attributed to intrapartum-related events. In 2010, 1.15 million babies (uncertainty range: 0.89–1.60 million; 8.5 cases per 1,000 live births) were estimated to have developed NE associated with intrapartum events, with 96% born in low- and middle-income countries, as compared with 1.60 million in 1990 (11.7 cases per 1,000 live births). An estimated 287,000 (181,000–440,000) neonates with NE died in 2010; 233,000 (163,000–342,000) survived with moderate or severe neurodevelopmental impairment; and 181,000 (82,000–319,000) had mild impairment. In GBD2010, intrapartum-related conditions comprised 50.2 million DALYs (2.4% of total) and 6.1 million YLDs. Intrapartum-related conditions are a large global burden, mostly due to high mortality in low-income countries. Universal coverage of obstetric care and neonatal resuscitation would prevent most of these deaths and disabilities. Rates of impairment are highest in middle-income countries where neonatal intensive care was more recently introduced, but quality may be poor. In settings without neonatal intensive care, the impairment rate is low due to high mortality, which is relevant for the scale-up of basic neonatal resuscitation.
420 citations
••
TL;DR: Developing effective means of prevention of preterm birth should be a longer term priority, but major burden reduction could be made immediately with improved coverage and quality of care.
Abstract: Background: In 2010, there were an estimated 15 million preterm births worldwide ( 90%) survive without neurodevelopmental impairment. Developing effective means of prevention of preterm birth should be a longer term priority, but major burden reduction could be made immediately with improved coverage and quality of care. Improved newborn care would reduce mortality, especially in low-income countries and is likely to reduce impairment in survivors, particularly in middle-income settings.
356 citations
••
Liverpool School of Tropical Medicine1, Bill & Melinda Gates Foundation2, The Global Fund to Fight AIDS, Tuberculosis and Malaria3, Centers for Disease Control and Prevention4, University of the Witwatersrand5, Institut de recherche pour le développement6, Rothamsted Research7, University of Oxford8, University of London9
TL;DR: To combat the threat of resistance, key stakeholders need to rapidly embrace a multifaceted approach including a reduction in the cost of bringing new resistance management methods to market and the streamlining of associated development, policy, and implementation pathways to counter this looming public health catastrophe.
348 citations
Authors
Showing all 190 results
Name | H-index | Papers | Citations |
---|---|---|---|
Martin McKee | 138 | 1732 | 125972 |
Scott G. Filler | 75 | 298 | 24377 |
Rifat Atun | 75 | 476 | 21404 |
Bernard L. Nahlen | 61 | 118 | 12173 |
Linda Richter | 61 | 325 | 20160 |
Richard G A Feachem | 51 | 158 | 11465 |
Richard Coker | 43 | 302 | 6947 |
Jeffrey V. Lazarus | 42 | 269 | 15436 |
Eline L. Korenromp | 41 | 98 | 5552 |
Jan H. Kolaczinski | 33 | 58 | 2723 |
Mark Dybul | 33 | 61 | 4171 |
Bernhard Schwartländer | 32 | 52 | 4095 |
Jinkou Zhao | 32 | 114 | 3269 |
Shiv Lal | 31 | 74 | 4709 |
Kalipso Chalkidou | 31 | 166 | 5503 |